Related Experiment Videos

CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis

R Riikonen1, S L Vanhanen, J Tyynelä

  • 1University Hospital of Kuopio, Helsinki, Finland. raili.riikonen@kolumbus.fi

Neurology
|May 10, 2000
PubMed

Insights

Infantile neuronal ceroid lipofuscinosis (INCL) is linked to low insulin-like growth factor-1 (IGF-1). This finding may explain the neurodegeneration and developmental issues seen in INCL patients.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Infantile neuronal ceroid lipofuscinosis (INCL) is a severe, progressive neurodegenerative disorder.
  • Characterized by cerebral atrophy, neuronal loss, and white matter damage, INCL typically manifests by age 3.
  • INCL results from palmitoyl protein thioesterase deficiency, with potential roles for growth factors and apoptosis.

Purpose of the Study:

  • To investigate the role of insulin-like growth factors (IGFs) in INCL pathogenesis.
  • To measure IGF-1 and IGF binding protein 3 (IGFBP-3) levels in INCL patients.

Main Methods:

  • Radioimmunoassay was used to quantify IGF-1 and IGFBP-3 in cerebrospinal fluid (CSF).
  • Measurements were taken at an early disease stage, coinciding with initial myelin degradation.
  • Biopsies were examined for evidence of apoptotic cell death.

Main Results:

  • CSF levels of IGF-1 were significantly lower in INCL patients compared to controls.
  • CSF levels of IGFBP-3 were found to be normal in INCL patients.
  • Apoptotic cell death was observed in tissue samples from INCL patients.

Conclusions:

  • The IGF system is crucial for neurodevelopment, myelination, and neuroprotection.
  • Reduced CSF IGF-1 levels may contribute to the observed pathology in INCL.
  • This suggests a potential link between IGF-1 deficiency and INCL progression.
Abstract

Related Concept Videos